Literature DB >> 6334073

Development of resistance to beta-lactam antibiotics with special reference to third-generation cephalosporins.

E Collatz, L Gutmann, R Williamson, J F Acar.   

Abstract

The resistance mechanisms associated with changes in the outer membrane permeability and in beta-lactamase and penicillin-binding-protein production are reviewed. The prevalence of membrane permeability- and chromosome-mediated beta-lactamase-related resistance in Gram-negative bacteria, and of PBP-related resistance in Gram-positive bacteria, with respect to third-generation cephalosporins, is outlined. The frequency of overall resistance to these compounds in two Parisian hospitals during 1983 did not exceed 2% in Enterobacteriaceae but was close to 15% in Pseudomonas sp.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334073     DOI: 10.1093/jac/14.suppl_b.13

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  Bacteraemia caused by Escherichia coli and by Enterobacteriaceae producing inducible chromosomal beta-lactamases.

Authors:  P Søgaard; P Tauris
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

2.  Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unit.

Authors:  M H Prevot; A Andremont; H Sancho-Garnier; C Tancrede
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

Review 3.  Clinical importance of inducible beta-lactamases in gram-negative bacteria.

Authors:  C C Sanders; W E Sanders
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

4.  Jacques F. Acar (1931-2020).

Authors:  E Cambau; L Gutmann; J-L Mainardi; F Goldstein; A Buu-Hoi; E Collatz; M Poljak; G Kahlmeter; I Phillips; F Baquero
Journal:  Clin Microbiol Infect       Date:  2020-06-11       Impact factor: 8.067

Review 5.  Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.

Authors:  A Adu; C L Armour
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

6.  In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.

Authors:  A Vuye; J Pijck
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

7.  Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections.

Authors:  R Piccolomini; L Cellini; N Allocati; A Di Girolamo; G Ravagnan
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

8.  Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit.

Authors:  N Modi; V Damjanovic; R W Cooke
Journal:  Arch Dis Child       Date:  1987-02       Impact factor: 3.791

9.  Serotype-specific evolutionary patterns of antimicrobial-resistant Salmonella enterica.

Authors:  Jingqiu Liao; Renato Hohl Orsi; Laura M Carroll; Jasna Kovac; Hongyu Ou; Hailong Zhang; Martin Wiedmann
Journal:  BMC Evol Biol       Date:  2019-06-21       Impact factor: 3.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.